Driving simulator improves driving safety
- Trial ID
- NCT06320639
- Official Title
- Driving Simulator and People With Neurocognitive Disorders
- Goal
- Driving simulator improves driving safety
- Status
- RECRUITING
- Sponsor
- University Gustave Eiffel
- Study Type
- OBSERVATIONAL
- Enrollment
- 150 participants
- Conditions
- Neurocognitive Disorders
Plain-Language Summary
They want to clarify how neurocognitive disorders affect real-world driving skills, so clinicians can better identify specific driving errors and safety risks. Participants drive in a realistic simulator while researchers measure things like lane keeping, reaction time, braking and hazard response, and record collisions, this is purely observational and not testing a drug or device. The trial seeks 50 to 95-year-olds diagnosed with a DSM-V neurocognitive disorder who have a B license with 3+ years driving experience and are active drivers or stopped less than two months ago, with normal or corrected vision and appropriate consent or a legal representative; people with epilepsy, vestibular problems or severe motion sickness, certain psychiatric histories or unstable psychiatric medications, recent alcoholism, use of anti-epileptics, or major walking-limiting joint problems are excluded.
Locations
- Hôpital des Charpennes, Villeurbanne, France
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. They want to clarify how neurocognitive disorders affect real-world driving skills, so clinicians can better identify specific driving errors and safety risks. Participants drive in a realistic simulator while researchers measure things like lane keeping, reaction time, braking and hazard response, and record collisions, this is purely observational and not testing a drug or device. The trial seeks 50 to 95-year-olds diagnosed with a DSM-V neurocognitive disorder who have a B license with 3+ years driving experience and are active drivers or stopped less than two months ago, with normal or corrected vision and appropriate consent or a legal representative; people with epilepsy, vestibular problems or severe motion sickness, certain psychiatric histories or unstable psychiatric medications, recent alcoholism, use of anti-epileptics, or major walking-limiting joint problems are excluded.
- Who can participate?
- Participants must be between 50 Years and 95 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 3 years.